Axel Pähler

1.2k citations
34 papers · 892 indexed · h-index 16
Topics
Pharmacogenetics and Drug Metabolism (11 papers)Metabolomics and Mass Spectrometry Studies (8 papers)Carcinogens and Genotoxicity Assessment (6 papers)

In The Last Decade

Axel Pähler

32 papers receiving 865 citations

Peers

Axel Pähler
Comparison fields: 5 of 96
  • Molecular Biology 414
  • Pharmacology 193
  • Computational Theory and Mathematics 173
  • Cancer Research 117
  • Spectroscopy 116
Replace Toshimasa Itoh with:
Toshimasa Itoh Japan
Mainak Mal India
Maryam Foroozesh United States
Andrew D. Ayrton United Kingdom
Anders Tunek Sweden
Ronald B. Franklin United States
Todd D. Porter United States
Yasuo Ohno Japan
Christine Beedham United Kingdom
Ylva Terelius Sweden
Axel Pähler relative to Toshimasa Itoh Japan Toshimasa Itoh's profile →
Citations per field
00.5×1.5×2.5×
Toshimasa Itoh · 1×
Citations per year

Countries citing papers authored by Axel Pähler

Since Specialization
Citations

This map shows the geographic impact of Axel Pähler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Pähler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Pähler more than expected).

Fields of papers citing papers by Axel Pähler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Pähler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Pähler. The network helps show where Axel Pähler may publish in the future.

Co-authorship network of co-authors of Axel Pähler

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Pähler. A scholar is included among the top collaborators of Axel Pähler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Pähler. Axel Pähler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 8
5 75
6 1
7 30
8 12
9 31
10 17
11 12
12 14
13 28
14 62
15 20
16 15
17 6
18 14
19 57
20 8

About Axel Pähler

Axel Pähler is a scholar working on Pharmacology, Biochemistry and Pharmaceutical Science, having authored 34 papers that have together received 892 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Carcinogens and Genotoxicity Assessment (6 papers). The work is most often cited by research in Pharmacology (193 citations), Biochemistry (104 citations) and Computational Theory and Mathematics (173 citations). Axel Pähler has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Wolfgang Völkel, W. Dekant, Rubén Alvarez‐Sánchez, Lutz Müller, Wolfgang Muster, Alexander Breidenbach, Holger Fischer, Stephan Kirchner, Andreas Brink and Jean Parker. Their work appears in journals such as Neuron, Analytical Chemistry and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026